Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study.
Noujaim J, Gupta AA, Holloway CL, Saleh R, Srikanthan A, Lemieux C, Soroka HP, Tibout P, Turcotte R, Feng X, Abdul Razak AR, Costa P.
Noujaim J, et al. Among authors: saleh r.
Eur J Cancer. 2024 May 14;205:114119. doi: 10.1016/j.ejca.2024.114119. Online ahead of print.
Eur J Cancer. 2024.
PMID: 38759389
Free article.